XLO (Xilio Therapeutics, Inc. Common Stock) Stock Analysis - Analyst Ratings

Xilio Therapeutics, Inc. Common Stock (XLO) is a publicly traded Healthcare sector company. As of May 21, 2026, XLO trades at $8.44 with a market cap of $48.76M and a P/E ratio of -1.97. XLO moved +1.83% today. Year to date, XLO is -10.87%; over the trailing twelve months it is -32.88%. Its 52-week range spans $6.47 to $23.80. Rallies surfaces XLO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate XLO?

The average price target is $0.00.

XLO Key Metrics

Key financial metrics for XLO
MetricValue
Price$8.44
Market Cap$48.76M
P/E Ratio-1.97
EPS$-4.19
Dividend Yield0.00%
52-Week High$23.80
52-Week Low$6.47
Volume0
Avg Volume0
Revenue (TTM)$43.77M
Net Income$-35.04M
Gross Margin0.00%

XLO Analyst Consensus

XLO analyst coverage data. Average price target: $0.00.

Latest XLO News

Recent XLO Insider Trades

  • Shannon James Samuel bought 5.00K (~$43.95K) on Mar 26, 2026.
  • Brennan Kevin M. sold 1.83K (~$1.17K) on Jan 2, 2026.
  • Frankenfield Christopher James sold 7.03K (~$4.52K) on Jan 2, 2026.

Common questions about XLO

What do analysts rate XLO?
The average price target is $0.00.
Does Rallies show XLO price targets?
Yes. Rallies tracks XLO analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is XLO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XLO. It does not provide personalized investment advice.
XLO

XLO